pharma news today obesity drugs glp-1 october 2025 Market Obesity drugs could fuel the
Description
sales of GLP-1 drugs were $13.7 billion.
Primary outcomes included changes in TTR, INR, and INR recheck frequency
Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.
Experience a fresher, delicate state with enhanced comfort
The GLP-1 receptor assay is a powerful tool for the identification of GLP-1 receptor agonists aimed at treating obesity and type 2 diabetes
